Podocyte loss was well known in type 2 diabetic nephropathy patients. The objective of the present study was to determine the number of podocytes and the degree of albuminuria in diabetic KK-A y /Ta (KK-A y ) mice which had been reported as diabetic nephropathy model. Diabetic KK-A y mice, diabetic KK/Ta mice and nondiabetic BALB/cA Jcl (BALB/cA) mice were studied. We analyzed glomerular lesions in all mice by morphometric analysis and immunofluorescence to determine the number of podocytes. Level of urinary albumin was also measured. Glomerular enlargement and mesangial expansion were observed in KK-A y mice. Mean number of podocytes per glomerulus (NG pod) in diabetic KK-A y mice was significantly lower than that in non-diabetic BALB/cA mice. Mean NG pod/glomerular area (GA) per glomerulus was also significantly decreased in diabetic KK-A y mice. The level of urinary albumin/creatinine ratio (ACR) in diabetic KK-A y mice was significantly higher than that in non-diabetic BALB/cA mice. These data suggest that podocyte loss might induce albuminuria in KK-A y mice. This finding confirmed our previous report that KK-A y mice, especially in terms of histological findings, are a suitable animal model for glomerular injury in type 2 diabetic nephropathy.
INTRODUCTION
Morphometric analysis has contributed greatly to our understanding of diabetic nephropathy [1] [2] [3] . Generally, the progression of nephropathy was associated with a reduction in the number of podocytes per glomerulus. Remaining podocytes were obligated to grow and to extend their foot processes to maintain the area covered. We previously reported that podocyte injury might provide additional prognostic information in patients with IgA nephropathy, the most common chronic glomerulonephritis, using a small amount of renal biopsy tissue [4] . Lemley et al. [5] reported podocytopenia (podocyte loss) and disease activity in patients with IgA nephropathy. However, glomerular structure in type 2 diabetes has been studied less extensively although this form of diabetes is a more common cause of end stage kidney disease. Macedo et al. [6] reported that the control of hyperglycemia prevented glomerular basement membrane (GBM) thickening in early and late (12 months) alloxan diabetic nephropathy and podocyte number reduction.
The KK/Ta mouse, a model of type 2 diabetic nephropathy, was established from Japanese native mice as an inbred mouse by Kondo et al. in 1957 [7] . This mouse is generally considered to be a polygenic disease model. Male KK/Ta mice spontaneously exhibit type 2 diabetes associated with hyperglycemia, glucose intolerance, hyperinsulinemia, mild obesity and microalbuminuria more severe than those in the female [8] [9] [10] . KK-A y mice showed obesity, hyperglycemia including high levels of HbA1c and albuminuria [11] . The pathological changes of glomeruli in KK-A y mice were consistent with those in the early stage of human diabetic nephropathy. The renal histological changes in KK-A y mice are more severe than those in KK/Ta mice. Advanced glycation end products (AGE) and transforming growth factor-beta (TGF-b) protein appeared to be localized in the glomerular mesangial areas [11] . It appears that KK-A y mice, especially in terms of histopathological findings, are a suitable animal model for the early stage of type 2 diabetic nephropathy.
The objective of the present study was to determine the number of podocytes and the degree of albuminuria in KK-A y mice.
MATERIALS AND METHODS

Animals
Male diabetic KK-A y /Ta (KK-A y ) mice, male diabetic KK/Ta Jcl (KK/Ta) mice and male non-diabetic BALB/ cA Jcl (BALB/cA) mice at 20 weeks after birth were obtained from CLEA Japan Inc. (Tokyo, Japan). Mice were housed individually in air-conditioned specific pathogen-free (SPF) animal quarters kept at 24˚C ± 1˚C with lighting from 8:00 AM to 9:00 PM, and given unrestricted access to special food (rodent pellet diet NMF; 348 kcal/100g, containing 5.5% crude fat, CLEA Japan Inc., Tokyo, Japan) and water throughout the experimenttal period of 20 weeks. All animals received humane care in compliance with the experimental protocol approved by the Committee of Laboratory Animals according to institutional guidelines.
Biochemical Findings
At 8, 12, 16 and 20 weeks of age, body weight (BW) was checked, and urinary albumin/creatinine ratio (ACR) and hemoglobin A1c (HbA1c) were measured. At 8 and 20 weeks of age, blood pressure was checked by a noninvasive tail cuff and pulse transducer system (Softron BP-98A, Tokyo, Japan) at 11:00 AM after the mice were externally prewarmed at 38˚C for 10 min. After repetition of each measurement (from 3 to 6 times), standard deviations of less than 10.0 were defined as the blood pressure levels. At the same weeks of age, levels of fasting and casual blood glucose were measured.
Metabolic cages obtained from CLEA Japan Inc. (Tokyo, Japan) were used for collecting of urinary samples for 24 hours. To measure urinary albumin and creatinine at 8, 12, 16 and 20 weeks of age, an immunoassay was performed using a commercial kit (DCA 2000 system, Bayer Diagnostics, Elkhart, IN, USA) [12] . Glucose taken from the retro-orbital sinus was measured using a commercial kit (Glucocard; Kyoto Daiichi Kagaku, Kyoto, Japan).
Morphometric Analysis by Light and Immunofluorescent Microscopy
Mice of all groups were sacrificed by exsanguination from the inferior vena cava at 20 weeks and the kidneys were perfused by saline via the left ventricle for 5 min at a pressure of 150 mmHg without prior flushing of the vasculature. Renal, urine and serum samples were kept frozen at −80˚C until assayed. Renal tissues of these mice fixed in 20% formaldehyde were embedded in paraffin and cut serially to obtain 3-um thick sections. All sections were mounted on glass slides. Formalin-fixed, paraffin-embedded renal sections were deparaffinized, and stained with periodic-acid Schiff (PAS).
Immunofluorescent staining for podocytes in renal tissues was performed using the polyclonal rabbit antimouse WT1 antibody (IgG) (Santa Cruz, SC-192). Cryostat 3 μm renal sections were air-dried for 10 min and fixed in cold acetone for 10 min. To reduce the background, the non-specific binding was blocked by incubating with blocking solution (as above) for 30 min. Non-specific staining was blocked by incubation for 15 min with avidin and biotin using the avidin-biotin blocking kit (Vector Laboratories). The sections were then incubated with the primary antibody (Ab) diluted 1:25 in the blocking solution at room temperature for 60 min. The primary Ab used was polyclonal rabbit anti-mouse WT-1 antibody (IgG) (Santa Cruz, SC-192). The sections were then incubated at room temperature for 30 min. Goat anti-rabbit Alexa Fluor 488 was used to visualize WT-1 positive cells (podocytes). The sections were mounted with a fluorescent mounting media (Dako Cytomation) before visualization with a Fluoview 1000 confocal microscope (Olympus, Tokyo, Japan) and FV10-ASWsoftware (version 1.3c; Olympus).
Sixty one, 70 and 90 midsections of glomeruli taken from KK-A y , KK/Ta and BALB/cA mice, respectively, were used in this study. Renal specimens were observed and photographed using a microscope equipped with a digital imaging system (Leica DM 2000, Leica Microsystems GmbH., Germany). The prints of each glomerulus in a ×400 field on each specimen were used. In the section, the glomerular tufts were carefully traced by hands with a pencil marker and prepared for the analysis. Morphometrical analysis was performed using a KS-400 version 4.0 image analysis system (KS-400, Carl Zeiss Vision, Munich, Germany). The number of podocytes per glomerulus (NG pod) and glomerular area (GA) were determined using the method of Weibel [13] . Ratio of NG pod to GA (NG pod/GA) was also calculated. Specimens with glomerular lesions such as sclerosis, adhesion and/or crescents in KK-A y mice at 20 weeks of age were excluded from the calculation of podocytes. These examinations were performed by two investigators without knowledge of the origin of the slides and then mean values were calculated. and then washed with PBS. Terminal deoxynucleotidyl transferase (TdT) and biotin-11-dUTP were supplemented followed by incubation for 60 min. Then, the sections were washed with PBS, incubated with avidinbiotinylated horseradish peroxidase complex followed by color development with DAB. Counter-staining for nuclei, dehydration, clearing and mounting were performed. Cells with brown granules in nuclei were TUNEL positive cells and TUNEL positive podocytes on the GBM were counted in 30 glomeruli of transverse section. Results were expressed as average numbers of TUNELpositive podocytes per glomerulus.
Statistical Analysis
Data were expressed as mean ± SD or mean ± SE. Statistical differences between means were determined using analysis of variance (ANOVA) on ranks followed by a post hoc test (Student-Newman-Keuls all pairwise comparison procedures). Statistical significance of % survival was determined by the log-rank test. A value of p < 0.05 was specified before the study to indicate significance.
RESULTS
Phenotypes
Levels of urinary albumin/creatinine ratio (ACR) of diabetic KK-A y mice were significantly higher than those of non-diabetic BALB/cA mice and KK/Ta mice at all time points (p < 0.001) (Figure 1) . The levels of BW in all strains mice increased gradually after 8 weeks of age. These levels in KK-A y mice were significantly higher than those in BALB/cA mice and KK/Ta mice (p < 0.001) ( Table 1 ). The levels of HbA1c in KK-A y mice were also significantly higher than those in BALB/cA mice and KK/Ta mice (p < 0.001). The levels of fasting blood glucose in KK-A y mice were did not change among three strains. No significant changes were observed in the levels of systolic, diastolic and mean blood pressure among three strains mice at 8 and 20 weeks of age ( Table 1) .
Glomerular Changes
In light microscopy, diffuse expansion of glomerular mesangial matrices was observed in diabetic KK-A y mice (Figure 2 ). Sclerosed lobules with several homogenous PAS-positive hyaline caps were found at 20 weeks of age.
Number of Podocytes
Mean podocyte numbers per glomerulus (NG pod) in diabetic KK-A y mice (mean ± SD: 8.73 ± 2.54) and KK/Ta mice (mean ± SD: 7.84 ± 1.93) were significantly lower than those in non-diabetic BALB/cA mice (mean ± SD: 9.47 ± 2.58) (KK-A y vs BALB/cA: p < 0.05, KK/Ta vs BALB/cA: p < 0.01) (Figure 3(a) ).
A significant change in the glomerular area (GA) was observed among diabetic KK-A y mice (mean ± SD: 5924.8 ± 1846.4), KK/Ta mice (mean ± SD: 4372.7 ± 1232.3) and non-diabetic BALB/cA mice (mean ± SD: 3738 ± 1338.4) (KK-A y vs BALB/cA: p < 0.001, KK/Ta vs BALB/cA: p < 0.01) (Figure 3(b) ). Mean number of podocytes per 1,000 μm 2 of glomerular area (GA) in diabetic KK-A y mice (mean ± SD: 1.6 ± 0.6) and KK/Ta mice (mean ± SD: 1.9 ± 0.6) were significantly lower than that in non-diabetic BALB/cA mice (mean ± SD: 2.7 ± 0.9) (p < 0.001) (Figure 3(c) ). 
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TUNEL Staining
TUNEL staining was performed to detect the number of apoptotic cells per glomerulus in KK-A y mice. An apoptotic cell was observed only one out of 30 glomeruli in KK-A y mice (Figure 4 ).
DISCUSSION
In human diabetic nephropathy, the common pathological features are glomerular enlargement, mesangial matrix expansion, segmental nodular sclerosis and glomerular basement membrane (GBM) thickening associated with albuminuria. AGE and TGF-b products have been implicated in the pathogenesis of human diabetic nephropathy [14, 15] . Recently, we reported that KK-A y mice exhibited type 2 diabetes and diabetic nephropathy from 8 to 20 weeks of age [11] . In PAS and PAM staining of specimens from KK-A y mice, we observed segmental sclerosis in some glomeruli at 20 weeks of age. In immunohistochemistry, AGE and TGF-b were marked in the glomerular mesangial areas [11] . The findings for albuminuria and GBM thickening in KK-A y mice were consistent with the duration of diabetes. It was clear that the KK-A y mouse might be a useful model of the early stage of type 2 diabetic nephropathy [11] . Pagtalunan et al. [16] reported that GBM thickness was increased and podocyte foot processes were broadened. Broadening of podocyte foot processes was associated with a reduction in the number per glomerulus and an increase in the surface area covered by remaining podocytes from Pima Indians with type 2 diabetes. Madedo et al. [5] reported that the control of hyperglycemia prevented GBM thickening in early and late (12 months) alloxan induced type 1 diabetic nephropathy and podocyte number reduction. In this study, KK-A y mice at 20 weeks of age showed diffuse expansion of glomerular mesangial matrices with segmental sclerosis and homogenous PAS-positive hyaline caps. Mean podocyte number per glomerulus (NG pod) in diabetic KK-A y mice was significantly lower than that in non-diabetic BALB/cA mice. Mean NG pod/ GA per glomerulus was also significantly decreased in diabetic KK-A y mice. In immunofluorescence, a decrease of WT-1 positive cells (podocytes) in glomeruli was observed in diabetic KK-A y mice. The level of urinary albumin/creatinine ratio (ACR) in diabetic KK-A y mice was significantly higher than that in non-diabetic BALB/ cA mice at 20 weeks of age. We previously reported that NG pod was negatively correlated with urinary protein excretion in patients with IgA nephropathy [4] . The general mechanisms of podocyte loss are considered as follows: detachment of intact podocytes from the GBM due to necrosis, apoptosis and/or autophagy [17] . In this study, apoptotic cells in glomerulus were examined in diabetic KK-A y mice using TUNEL staining. An apoptotic cell was observed only one out of 30 glomeruli in KK-A y mice. In human diabetic nephropathy, there is no evidence of necrosis and no direct evidence for apoptosis as a major mechanism of podocyte loss. However, apoptosis of podocytes has been determined in cell cultures [18, 19] . Gu et al. reported that monocyte chemoattractant protein-1 (MCP-1) was induced by advanced glycation end-products and carboxymethllysine (CML) in differentiated podocytes [20] . It is speculated that MCP-1/ cysteine-cysteine chemokine receptor 2 (CCR2) system is involved in the apoptosis of podocytes in diabetic nephropathy. The detachment of intact podocytes from the GBM has been reported in Japanese diabetic patients [21] . Nakamura et al. [21] indicated that podocytes in the urine may be a useful marker of disease activity in patients with diabetic nephropathy. The excretion of podocytes into the urine (podocyte loss) and subsequent hypertrophy may reflect disease activity in glomerular disease [4, 22] . Podocytes in adults did not undergo mitosis. Normally the only way to respond to injury is by cell hypertrophy. Thus, increased podocyte surface area reflects the extent of podocyte hypertrophy. Since the extent of podocyte hypertrophy is limited, segments of the GBM become denuded in severe cases. Direct contact of the naked portion of the GBM with the parietal epithetlium of Bowman's capsule might lead to adhesion to Bowman's capsule and potential segmental sclerosis [23, 24] . It appears that podocyte loss, i.e. podocytopenia, might induce albuminuria in diabetic KK-A y mice. This finding confirmed our previous report that KK-A y mice, especially in terms of histological findings, are a suitable animal model for glomerular injury in human type 2 diabetic nephropathy.
CONCLUSION
The results of the present study indicated that podo- 
